Yu Chen

Suzhou Porton Biologics Ltd. is a gene and cell therapy CDMO founded in 2018. The company is based in Suzhou, China. The Chinese company provides end-to-end services, including process development, analytical methods development, cGMP production, and analytical testing and consulting services to meet the therapeutic product needs of different stages of commercial production, from preclinical to commercial production.

Suzhou Porton Biologics Ltd. is a gene and cell therapy CDMO founded in 2018. The company is based in Suzhou, China. The Chinese company provides end-to-end services, including process development, analytical methods development, cGMP production, and analytical testing and consulting services to meet the therapeutic product needs of different stages of commercial production, from preclinical to commercial production.

Suzhou Porton Biologics Ltd. is a gene and cell therapy CDMO founded in 2018. The company is based in Suzhou, China. The Chinese company provides end-to-end services, including process development, analytical methods development, cGMP production, and analytical testing and consulting services to meet the therapeutic product needs of different stages of commercial production, from preclinical to commercial production.

Suzhou Porton Biologics Ltd. is a gene and cell therapy CDMO founded in 2018. The company is based in Suzhou, China. The Chinese company provides end-to-end services, including process development, analytical methods development, cGMP production, and analytical testing and consulting services to meet the therapeutic product needs of different stages of commercial production, from preclinical to commercial production.

Suzhou Porton Biologics Ltd. is a gene and cell therapy CDMO founded in 2018. The company is based in Suzhou, China. The Chinese company provides end-to-end services, including process development, analytical methods development, cGMP production, and analytical testing and consulting services to meet the therapeutic product needs of different stages of commercial production, from preclinical to commercial production.